Diseases

The Sabin Vaccine Institute works to extend the benefits of immunization to all people by enabling vaccine access and uptake. Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines. Our work includes a number of diseases, including:

Supporting Evidence-Based Decisions

Vaccine introduction, policy and financing are complex issues, and countries must achieve ambitious immunization targets with limited available resources. To make informed decisions for the health of their people, decision makers need accurate, up-to-date information to identify vulnerable populations, assess burden of disease, evaluate vaccine efficacy and cost-effectiveness, and measure the efficiency of immunization programs.

With final exams approaching throughout universities across the United States, the beginning of the semester – particularly the boring details of packing and moving and, oh, getting your updated vaccines – seems like a distant memory.  

Meningococcal Disease

The onset of meningitis can occur suddenly and progress rapidly, with the potential to become fatal within a matter of hours. Survivors can be left with debilitating neurological side effects ranging from speech disorders to mental retardation and paralysis.

Since 2011, Sabin has worked to improve meningococcal disease estimates, focusing on Latin America. Through regional symposia, research and advocacy, Sabin provides a broader base of knowledge on which to build future initiatives, while bringing together key stakeholders to better understand and fight meningococcal disease.

Each year since 1994 the Sabin Vaccine Institute has  recognized distinguished members of the scientific community  with its highest honor, the Albert B. Sabin Gold Medal Award.  Gold Medal Award winners have made significant contributions  to vaccinology or a complementary field.

Few illnesses have as much power to cause panic among the population as meningococcal disease. And the facts are scary: meningococcal disease is one of the most severe and rapidly progressive community acquired infections.

03.19.13 to 03.20.13
Buenos Aires, Argentina

Pages

Subscribe to RSS - meningococcal